-
1
-
-
0028344535
-
Tumor antigens recognized by T lymphocytes
-
Boon, T., Cerottini, J. C., Van den Eynde, B., van der Bruggen, P., and Van Pel, A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol., 12: 337-365, 1994.
-
(1994)
Annu. Rev. Immunol.
, vol.12
, pp. 337-365
-
-
Boon, T.1
Cerottini, J.C.2
Van Den Eynde, B.3
Van Der Bruggen, P.4
Van Pel, A.5
-
2
-
-
0027087331
-
Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
-
Schwanz, R. H. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell, 71: 1065-1068, 1992.
-
(1992)
Cell
, vol.71
, pp. 1065-1068
-
-
Schwanz, R.H.1
-
3
-
-
0027964431
-
The B7 and CD28 receptor families
-
June, C. H., Bluestone, J. A., Nadler, L. M., and Thompson, C. B. The B7 and CD28 receptor families. Immunol. Today, 15: 321-331, 1994.
-
(1994)
Immunol. Today
, vol.15
, pp. 321-331
-
-
June, C.H.1
Bluestone, J.A.2
Nadler, L.M.3
Thompson, C.B.4
-
4
-
-
0029944533
-
CD28/B7 system of T cell costimulation
-
Lenschow, D. J., Walunas, T. L., and Bluestone, J. A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol., 14: 233-258, 1996.
-
(1996)
Annu. Rev. Immunol.
, vol.14
, pp. 233-258
-
-
Lenschow, D.J.1
Walunas, T.L.2
Bluestone, J.A.3
-
5
-
-
0027078670
-
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
-
Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71: 1093-1102, 1992.
-
(1992)
Cell
, vol.71
, pp. 1093-1102
-
-
Chen, L.1
Ashe, S.2
Brady, W.A.3
Hellstrom, I.4
Hellstrom, K.E.5
Ledbetter, J.A.6
McGowan, P.7
Linsley, P.S.8
-
6
-
-
0027439005
-
Costimulation of T cells for tumor immunity
-
Chen, L., Linsley, P. S., and Hellstrom, K. E. Costimulation of T cells for tumor immunity. Immunol. Today, 14: 483-486, 1993.
-
(1993)
Immunol. Today
, vol.14
, pp. 483-486
-
-
Chen, L.1
Linsley, P.S.2
Hellstrom, K.E.3
-
7
-
-
0027392843
-
Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells
-
Washington DC
-
Townsend, S. E., and Allison, J. P. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science (Washington DC), 259: 368-370, 1993.
-
(1993)
Science
, vol.259
, pp. 368-370
-
-
Townsend, S.E.1
Allison, J.P.2
-
8
-
-
0029310484
-
Can co-stimulated tumor immunity be therapeutically efficacious?
-
Hellstrom, K. E., Hellstrom, I., and Chen, L. Can co-stimulated tumor immunity be therapeutically efficacious? Immunol. Rev., 145: 123-145, 1995.
-
(1995)
Immunol. Rev.
, vol.145
, pp. 123-145
-
-
Hellstrom, K.E.1
Hellstrom, I.2
Chen, L.3
-
9
-
-
0028934350
-
Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules
-
Yang, G., Hellstrom, K. E., Hellstrom, I., and Chen, L. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J. Immunol., 154: 2794-2800, 1995.
-
(1995)
J. Immunol.
, vol.154
, pp. 2794-2800
-
-
Yang, G.1
Hellstrom, K.E.2
Hellstrom, I.3
Chen, L.4
-
10
-
-
9444225462
-
Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic antitumor immunity against different mouse tumors
-
Martin-Fontecha, A., Cavallo, F., Bellone, M., Heltai, S., Iezzi, G., Tornaghi, P., Nabavi, N., Forni, G., Dellabona, P., and Casorati, G. Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic antitumor immunity against different mouse tumors. Eur. J. Immunol., 26: 1851-1859, 1996.
-
(1996)
Eur. J. Immunol.
, vol.26
, pp. 1851-1859
-
-
Martin-Fontecha, A.1
Cavallo, F.2
Bellone, M.3
Heltai, S.4
Iezzi, G.5
Tornaghi, P.6
Nabavi, N.7
Forni, G.8
Dellabona, P.9
Casorati, G.10
-
11
-
-
0028979117
-
Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response
-
Cavallo, F., Martin-Fontecha, A., Bellone, M., Heltai, S., Gatti, E., Tornaghi, P., Freschi, M., Forni, G., Dellabona, P., and Casorati, G. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol., 25: 1154-1162, 1995.
-
(1995)
Eur. J. Immunol.
, vol.25
, pp. 1154-1162
-
-
Cavallo, F.1
Martin-Fontecha, A.2
Bellone, M.3
Heltai, S.4
Gatti, E.5
Tornaghi, P.6
Freschi, M.7
Forni, G.8
Dellabona, P.9
Casorati, G.10
-
12
-
-
0029070142
-
Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity
-
Geldhof, A B., Raes, G., Bakkus, M., Devos, S., Thielemans, K., and De Baetselier, P. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res., 55: 2730-2733, 1995.
-
(1995)
Cancer Res.
, vol.55
, pp. 2730-2733
-
-
Geldhof, A.B.1
Raes, G.2
Bakkus, M.3
Devos, S.4
Thielemans, K.5
De Baetselier, P.6
-
13
-
-
0028861977
-
A reassessment of the role of B7-1 expression in tumor rejection
-
Wu, T. C., Huang, A. Y., Jaffee, E. M., Levitsky, H. I., and Pardoll, D. M. A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med., 182: 1415-1421, 1995.
-
(1995)
J. Exp. Med.
, vol.182
, pp. 1415-1421
-
-
Wu, T.C.1
Huang, A.Y.2
Jaffee, E.M.3
Levitsky, H.I.4
Pardoll, D.M.5
-
14
-
-
0030273745
-
Triggering of natural killer cells by the costimulalory molecule CD80 (B7-1)
-
Chambers, B. J., Salcedo, M., and Ljunggren, H. G. Triggering of natural killer cells by the costimulalory molecule CD80 (B7-1). Immunity, 5: 311-317, 1996.
-
(1996)
Immunity
, vol.5
, pp. 311-317
-
-
Chambers, B.J.1
Salcedo, M.2
Ljunggren, H.G.3
-
15
-
-
0030913971
-
Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor α
-
Moro, M., Pelagi, M., Fulci, G., Paganelli, G., Dellabona, P., Casorati, G., Siccardi, A. G., and Corti, A. Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor α. Cancer Res., 57: 1922-1928, 1997.
-
(1997)
Cancer Res.
, vol.57
, pp. 1922-1928
-
-
Moro, M.1
Pelagi, M.2
Fulci, G.3
Paganelli, G.4
Dellabona, P.5
Casorati, G.6
Siccardi, A.G.7
Corti, A.8
-
16
-
-
0026070431
-
Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV-infected cells
-
Traunecker, A., Lanzavecchia, A., and Karjalainen, K. Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV-infected cells. EMBO J., 10: 3655-3659, 1991.
-
(1991)
EMBO J.
, vol.10
, pp. 3655-3659
-
-
Traunecker, A.1
Lanzavecchia, A.2
Karjalainen, K.3
-
17
-
-
0030844464
-
The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes
-
Iezzi, G., Rivolta, L., Ronchetti, A., Martin-Fontecha, A., Rosato, A., Protti, M. P., Sabbadini, M. G., and Bellone, M. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes. Cancer Res., 57: 2564-2568, 1997.
-
(1997)
Cancer Res.
, vol.57
, pp. 2564-2568
-
-
Iezzi, G.1
Rivolta, L.2
Ronchetti, A.3
Martin-Fontecha, A.4
Rosato, A.5
Protti, M.P.6
Sabbadini, M.G.7
Bellone, M.8
-
18
-
-
0032519413
-
Flowmicrofluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo
-
Brawand, P., Biasi, G., Horvath, C., Cerottini, J. C., and MacDonald, H. R. Flowmicrofluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo. J. Immunol., 160: 1659-1665, 1998.
-
(1998)
J. Immunol.
, vol.160
, pp. 1659-1665
-
-
Brawand, P.1
Biasi, G.2
Horvath, C.3
Cerottini, J.C.4
MacDonald, H.R.5
-
19
-
-
0031569119
-
Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation
-
Cayeux, S., Richter, G., Noffz, G., Dorken, B., and Blankenstein, T. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J. Immunol., 158; 2834-2841, 1997.
-
(1997)
J. Immunol.
, vol.158
, pp. 2834-2841
-
-
Cayeux, S.1
Richter, G.2
Noffz, G.3
Dorken, B.4
Blankenstein, T.5
-
20
-
-
0029163387
-
L
-
L. Immunity, 3: 87-98, 1995.
-
(1995)
Immunity
, vol.3
, pp. 87-98
-
-
Boise, L.H.1
Minn, A.J.2
Noel, P.J.3
June, C.H.4
Accavitti, M.A.5
Lindsten, T.6
Thompson, C.B.7
-
21
-
-
0029939945
-
The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
-
Van Parijs, L., Ibraghimov, A., and Abbas, A. K. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity, 4: 321-328, 1996.
-
(1996)
Immunity
, vol.4
, pp. 321-328
-
-
Van Parijs, L.1
Ibraghimov, A.2
Abbas, A.K.3
-
22
-
-
0031572579
-
Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis
-
Daniel, P. T., Kroidl, A., Cayeux, S., Bargou, R., Blankenstein, T., and Dorken, B. Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis. J. Immunol., 159: 3808-3815, 1997.
-
(1997)
J. Immunol.
, vol.159
, pp. 3808-3815
-
-
Daniel, P.T.1
Kroidl, A.2
Cayeux, S.3
Bargou, R.4
Blankenstein, T.5
Dorken, B.6
-
23
-
-
0031888608
-
Immunological ignorance of silent antigens as an explanation of tumor evasion
-
Chen, L. P. Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunol. Today, 19: 27-30, 1998.
-
(1998)
Immunol. Today
, vol.19
, pp. 27-30
-
-
Chen, L.P.1
-
24
-
-
0030026868
-
B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro
-
Gajewski, T. F. B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro. J. Immunol., 156: 465-472, 1996.
-
(1996)
J. Immunol.
, vol.156
, pp. 465-472
-
-
Gajewski, T.F.1
-
25
-
-
0030916031
-
Transfection of the gene for B7-1 but not B7-2 can induce immunity to murine malignant mesothelioma
-
Leong, C. C., Marley, J. V., Loh, S., Milech, N., Robinson, B. W., and Garlepp, M. J. Transfection of the gene for B7-1 but not B7-2 can induce immunity to murine malignant mesothelioma. Int. J. Cancer, 71: 476-482, 1997.
-
(1997)
Int. J. Cancer
, vol.71
, pp. 476-482
-
-
Leong, C.C.1
Marley, J.V.2
Loh, S.3
Milech, N.4
Robinson, B.W.5
Garlepp, M.J.6
-
26
-
-
0030028248
-
B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct
-
Matulonis, U., Dosiou, C., Freeman, G., Lamont, C., Mauch, P., Nadler, L. M., and Griffin, J. D. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J. Immunol., 156: 1126-1131, 1996.
-
(1996)
J. Immunol.
, vol.156
, pp. 1126-1131
-
-
Matulonis, U.1
Dosiou, C.2
Freeman, G.3
Lamont, C.4
Mauch, P.5
Nadler, L.M.6
Griffin, J.D.7
-
27
-
-
0028205164
-
Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits
-
Stella, M., De Nardi, P., Paganelli, G., Magnani, P., Mangili, F., Sassi, I., Baratti, D., Gini, P., Zito, F., Cristallo, M., Fazio, F., and DiCarlo, V. Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits. Dis. Colon Rectum, 37: 335-343, 1994.
-
(1994)
Dis. Colon Rectum
, vol.37
, pp. 335-343
-
-
Stella, M.1
De Nardi, P.2
Paganelli, G.3
Magnani, P.4
Mangili, F.5
Sassi, I.6
Baratti, D.7
Gini, P.8
Zito, F.9
Cristallo, M.10
Fazio, F.11
DiCarlo, V.12
-
28
-
-
0029035433
-
Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase
-
Yao, Z., Zhang, M., Kobayashi, H., Sakahara, H., Nakada, H., Yamashina, I., and Konishi, J. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase. J. Nucl. Med., 36: 837-841, 1995.
-
(1995)
J. Nucl. Med.
, vol.36
, pp. 837-841
-
-
Yao, Z.1
Zhang, M.2
Kobayashi, H.3
Sakahara, H.4
Nakada, H.5
Yamashina, I.6
Konishi, J.7
-
29
-
-
0029037106
-
Targeting cancer with radiolabeled antibodies
-
Goldenberg, D. M., Larson, S. M., Reisfeld, R. A., and Schlom, J. Targeting cancer with radiolabeled antibodies. Immunol. Today, 16: 261-264, 1995.
-
(1995)
Immunol. Today
, vol.16
, pp. 261-264
-
-
Goldenberg, D.M.1
Larson, S.M.2
Reisfeld, R.A.3
Schlom, J.4
-
30
-
-
0030915612
-
Cancer dormancy: Opportunities for new therapeutic approaches
-
Uhr, J. W., Scheuermann, R. H., Street, N. E., and Vitetta, E. S. Cancer dormancy: opportunities for new therapeutic approaches. Nat. Med., 3: 505-509, 1997.
-
(1997)
Nat. Med.
, vol.3
, pp. 505-509
-
-
Uhr, J.W.1
Scheuermann, R.H.2
Street, N.E.3
Vitetta, E.S.4
-
31
-
-
0030659504
-
Antibody-based immunological therapies
-
Scott, A. M., and Welt, S. Antibody-based immunological therapies. Curr. Opin. Immunol., 9: 717-722, 1997.
-
(1997)
Curr. Opin. Immunol.
, vol.9
, pp. 717-722
-
-
Scott, A.M.1
Welt, S.2
-
32
-
-
0027380021
-
Pretargeting of carcinomas with the avidin-biotin system
-
Paganelli, G., Magnani, P., and Fazio, F. Pretargeting of carcinomas with the avidin-biotin system. Int. J. Biol. Markers, 8: 155-159, 1993.
-
(1993)
Int. J. Biol. Markers
, vol.8
, pp. 155-159
-
-
Paganelli, G.1
Magnani, P.2
Fazio, F.3
-
33
-
-
0028221948
-
Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin
-
Saga, T., Weinstein, J. N., Jeong, J. M., Heya, T., Lee, J. T., Le, N., Paik, C. H., Sung, C., and Neumann, R. D. Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin. Cancer Res., 54: 2160-2165, 1994.
-
(1994)
Cancer Res.
, vol.54
, pp. 2160-2165
-
-
Saga, T.1
Weinstein, J.N.2
Jeong, J.M.3
Heya, T.4
Lee, J.T.5
Le, N.6
Paik, C.H.7
Sung, C.8
Neumann, R.D.9
-
34
-
-
0031194358
-
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development
-
Karacay, H., Sharkey, R. M., Govindan, S. V., McBride, W. J., Goldenberg, D. M., Hansen, H. J., and Griffiths, G. L. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development. Bioconjug. Chem., 8: 585-594, 1997.
-
(1997)
Bioconjug. Chem.
, vol.8
, pp. 585-594
-
-
Karacay, H.1
Sharkey, R.M.2
Govindan, S.V.3
McBride, W.J.4
Goldenberg, D.M.5
Hansen, H.J.6
Griffiths, G.L.7
-
35
-
-
0031193474
-
Development of a streptavidin-anticarcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model
-
Sharkey, R. M., Karacay, H., Griffiths, G. L., Sehr, T. M., Blumenthal, R. D., Mattes, M. J., Hansen, H. J., and Goldenberg, D. M. Development of a streptavidin-anticarcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model. Bioconjug. Chem., 8: 595-604, 1997.
-
(1997)
Bioconjug. Chem.
, vol.8
, pp. 595-604
-
-
Sharkey, R.M.1
Karacay, H.2
Griffiths, G.L.3
Sehr, T.M.4
Blumenthal, R.D.5
Mattes, M.J.6
Hansen, H.J.7
Goldenberg, D.M.8
-
36
-
-
0031973478
-
Effect Of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multistep targeting
-
Zhang, M. L., Yao, Z. S., Sakahara, H., Saga, T., Nakamoto, Y., Sato, N., Zhao, S. J., Nakada, H., Yamashina, I., and Konishi, J. Effect Of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multistep targeting. Nucl. Med. Biol., 25: 101-105, 1998.
-
(1998)
Nucl. Med. Biol.
, vol.25
, pp. 101-105
-
-
Zhang, M.L.1
Yao, Z.S.2
Sakahara, H.3
Saga, T.4
Nakamoto, Y.5
Sato, N.6
Zhao, S.J.7
Nakada, H.8
Yamashina, I.9
Konishi, J.10
-
37
-
-
0033564833
-
Tumor pre-targeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor a in a mouse model
-
in press
-
Gasparri, A., Moro, M., Curnis, F., Sacchi, A., Pagano, S., Veglia, F., Casoratio, G., Siccardi, A. G., Dellabona, P., and Corti, A. Tumor pre-targeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor a in a mouse model. Cancer Res., in press, 1999.
-
(1999)
Cancer Res.
-
-
Gasparri, A.1
Moro, M.2
Curnis, F.3
Sacchi, A.4
Pagano, S.5
Veglia, F.6
Casoratio, G.7
Siccardi, A.G.8
Dellabona, P.9
Corti, A.10
|